Cite
HARVARD Citation
Ruiz-Borrego, M. et al. (n.d.). Bringing diarrhea under CONTROL: dose escalation reduces neratinib-associated diarrhea and improves tolerability in HER2-positive early-stage breast cancer. Breast. pp. S18-S19. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ruiz-Borrego, M. et al. (n.d.). Bringing diarrhea under CONTROL: dose escalation reduces neratinib-associated diarrhea and improves tolerability in HER2-positive early-stage breast cancer. Breast. pp. S18-S19. [Online].